Literature DB >> 19328289

PDE4 inhibitors - a review of the current field.

Neil J Press1, Katharine H Banner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19328289     DOI： 10.1016/S0079-6468(08)00202-6

Source DB:  PubMed          Journal:  Prog Med Chem        ISSN： 0079-6468


× No keyword cloud information.
  17 in total

1.  Burkholderia as a Source of Natural Products.

Authors:  Sylvia Kunakom; Alessandra S Eustáquio
Journal:  J Nat Prod       Date:  2019-07-11       Impact factor: 4.050

2.  Treating brain tumors with PDE4 inhibitors.

Authors:  Rajarshi Sengupta; Tao Sun; Nicole M Warrington; Joshua B Rubin
Journal:  Trends Pharmacol Sci       Date:  2011-03-28       Impact factor: 14.819

3.  Roflumilast ameliorates cognitive impairment in APP/PS1 mice via cAMP/CREB/BDNF signaling and anti-neuroinflammatory effects.

Authors:  Huancun Feng; Canmao Wang; Wei He; Xinjun Wu; Shujie Li; Zhenkun Zeng; Meidan Wei; Binghong He
Journal:  Metab Brain Dis       Date:  2019-01-04       Impact factor: 3.584

4.  Metabolites from the induced expression of cryptic single operons found in the genome of Burkholderia pseudomallei.

Authors:  John B Biggins; Xiaofei Liu; Zhiyang Feng; Sean F Brady
Journal:  J Am Chem Soc       Date:  2011-01-19       Impact factor: 15.419

Review 5.  Role of cAMP and phosphodiesterase signaling in liver health and disease.

Authors:  Banrida Wahlang; Craig McClain; Shirish Barve; Leila Gobejishvili
Journal:  Cell Signal       Date:  2018-06-11       Impact factor: 4.315

6.  Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.

Authors:  P H Schafer; A Parton; A K Gandhi; L Capone; M Adams; L Wu; J B Bartlett; M A Loveland; A Gilhar; Y-F Cheung; G S Baillie; M D Houslay; H-W Man; G W Muller; D I Stirling
Journal:  Br J Pharmacol       Date:  2009-12-24       Impact factor: 8.739

Review 7.  Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD.

Authors:  Mark A Giembycz; Stephen K Field
Journal:  Drug Des Devel Ther       Date:  2010-07-21       Impact factor: 4.162

8.  Benzoquinones and terphenyl compounds as phosphodiesterase-4B inhibitors from a fungus of the order Chaetothyriales (MSX 47445).

Authors:  Tamam El-Elimat; Mario Figueroa; Huzefa A Raja; Tyler N Graf; Audrey F Adcock; David J Kroll; Cynthia S Day; Mansukh C Wani; Cedric J Pearce; Nicholas H Oberlies
Journal:  J Nat Prod       Date:  2013-01-09       Impact factor: 4.050

9.  Chronic Cognitive Dysfunction after Traumatic Brain Injury Is Improved with a Phosphodiesterase 4B Inhibitor.

Authors:  David J Titus; Nicole M Wilson; Julie E Freund; Melissa M Carballosa; Kevin E Sikah; Concepcion Furones; W Dalton Dietrich; Mark E Gurney; Coleen M Atkins
Journal:  J Neurosci       Date:  2016-07-06       Impact factor: 6.167

10.  A negative allosteric modulator of PDE4D enhances learning after traumatic brain injury.

Authors:  David J Titus; Nicole M Wilson; Oscar Alcazar; Dale A Calixte; W Dalton Dietrich; Mark E Gurney; Coleen M Atkins
Journal:  Neurobiol Learn Mem       Date:  2017-12-30       Impact factor: 2.877
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.